RecruitingNCT07542145
MDMA-assisted psychotherapy for bulimia nervosa
About this title
Read the official source — NCT07542145Medication studyAges 18+United StatesEating disorders
Understand this study
Who could participate?
Listed age limits: from 18 years.
- Listed locations
- New YorkSee all locations and recruitment
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: May 22, 2026
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 40
- Sponsor
- Icahn School of Medicine at Mount Sinai
- Sponsor type
- University
- Study type
- Behavioral
- Intervention type
- Behavioural, Drug
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
- Locations
- United States
- Age range
- Over 18 Years
- Official registry ID
- NCT07542145
- Official title
Show the full official title
MDMA Assisted Therapy for Bulimia Nervosa: A Treatment Development Protocol
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
New York
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Icahn School of Medicine at Mount Sinai, a university.
Does this study involve medication?
Yes. The study involves medication, including MDMA-AT and MDMA-AT-BN.
Who can participate?
Listed age limits: from 18 years.
Is this study still recruiting?
The registry lists this study as recruiting.
